Hope for Sky: A Treatment for an Ultra-Rare Disease

Foto della campagna Hope for Sky: A Treatment for an Ultra-Rare Disease, 1 di 7Foto della campagna Hope for Sky: A Treatment for an Ultra-Rare Disease, 1 di 7
Foto della campagna Hope for Sky: A Treatment for an Ultra-Rare Disease, 2 di 7

Skylar’s journey depends on gifts funding clinical trials for lifesaving treatment access

  • K
  • M
  • D
76 donatori
Foto della campagna Hope for Sky: A Treatment for an Ultra-Rare Disease, 4 di 7
Foto della campagna Hope for Sky: A Treatment for an Ultra-Rare Disease, 5 di 7
Foto della campagna Hope for Sky: A Treatment for an Ultra-Rare Disease, 6 di 7
Immagine principale della raccolta fondi
0% complete

9.160 $ raccolti su 75 mila $

‌

Hope for Sky: A Treatment for an Ultra-Rare Disease

Hope for Sky: A Treatment for an Ultra-Rare Disease

0% complete

9.160 $ raccolti su 75 mila $

76 donazioni
Donazione protetta
Our daughter Skylar has been defying the odds since the day she was born. She arrived prematurely, spent her first month in the NICU, and joined our family at just one month old. After a long and emotional journey, we officially adopted her at 2.5 years old.

Skylar is resilient, brave, and full of light—but her fight is far from over.

Just before her first birthday, she was diagnosed with Beta-Mannosidosis, an ultra-rare, progressive, and life-threatening lysosomal storage disorder with no approved treatment. It has caused vision and hearing loss, neuropathy, feeding challenges, and countless setbacks—yet she continues to fight with remarkable strength.

In hopes of slowing the disease, Skylar underwent a bone marrow transplant. Throughout this process, she faced months of life-threatening complications and spent over nine months in the hospital, including extended stays in the ICU. Despite this, she continues to show signs of disease progression.

Yet there is hope.

A targeted enzyme replacement therapy developed at UC Irvine has the potential to stop the progression of Beta-Mannosidosis. With incredible support, families like ours have already raised the funds needed for the preclinical studies, over $521,000!

Now we must move on to the next critical steps:

-Natural History Study – Required for FDA approval: $75,000

-Drug Manufacturing – Estimated cost: at least $3 million

-Clinical Trials – The final step to bring treatment to patients, this could cost families over 10 million dollars.

To drive this work, we co-founded The Lost Enzyme Project, dedicated to accelerating research and giving children with Beta-Mannosidosis a fighting chance. For more information, visit TLEP.org

Please consider donating, sharing this page, or helping us spread Skylar’s story. Every contribution brings us closer to a life-saving treatment—for Skylar and for children around the world facing this devastating diagnosis.

Skylar’s sign name means “brave” because she is stronger than life is hard, and we will never stop fighting for her.

With love and gratitude,
Nate & Erin Hubbard

#savingsky
#savingskylar
#betamannosidosis
#thesekidscantwait
#raredisease
#future4sky
#thelostenzymeproject




Dona

‌
‌‌
‌
‌‌
‌
‌‌
‌
‌‌
‌
‌‌

Organizzatore

Foto del profilo di Erin Hubbard
Erin Hubbard
Organizzatore
Chandler, AZ

Il luogo in cui puoi aiutare in modo facile, efficace e affidabile

  • È facile

    Fai una donazione in modo facile e veloce

  • Efficace

    Offri un aiuto diretto per le persone e le cause che ti stanno a cuore

  • Affidabile

    La tua donazione è protetta dalla Garanzia GoFundMe Giving